NCT05408572View on ClinicalTrials.gov

Study of SON-1010 (IL12-FHAB) in Healthy Adults

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 27, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

May 17, 2023

Conditions
Healthy Adult
Interventions
BIOLOGICAL

SON-1010 (IL12-FHAB)

SON-1010 is a single-chain human IL-12 cytokine linked to a single-chain variable region known as the FHAB.

Trial Locations (1)

3004

Nucleus Network Pty Ltd, Melbourne

Sponsors
All Listed Sponsors
lead

Sonnet BioTherapeutics

INDUSTRY

NCT05408572 - Study of SON-1010 (IL12-FHAB) in Healthy Adults | Biotech Hunter | Biotech Hunter